Vital Therapies reported $-21224000 in Pre-Tax Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Enanta Pharmaceuticals ENTA:US USD -26334000 5.81M
Insmed INSM:US USD -130773000 35.63M
Intercept Pharmaceuticals ICPT:US USD -104087000 83.77M
Mirati Therapeutics MRTX:US USD -173307000 3.14M
Omeros OMER:US USD -54792000 13.1M
Orasure Technologies OSUR:US USD 4.13M 24.1M
Regulus Therapeutics RGLS:US USD -7551000 293K
Revance Therapeutics RVNC:US USD -83993000 22.56M
Ultragenyx Pharmaceutical RARE:US USD -238819000 80.96M
United Therapeutics UTHR:US USD 312.5M 161.9M
Vital Therapies VTL:US USD -21224000 677K
Xoma XOMA:US USD -4178000 492K